TC BioPharm
- Home
- Companies
- TC BioPharm
- Applications
2 Applications found
TC BioPharm applications
This trial investigated the safety profile of large numbers of GDT cells derived from patients and was open to certain patients with skin, kidney or lung cancers. This trial is now closed.
This trial uses our unmodified GDT cells derived from healthy donors, in a dose escalation study to establish safety of the allogeneic platform. This trial is open.